• 心血管疾病论坛 •    

阿托伐他汀对急性冠脉综合症患者血清妊娠相关蛋白-A及C反应蛋白的影响

程爱娟   

  1. 天津市胸科医院
  • 收稿日期:2011-05-03 修回日期:2011-06-06 出版日期:2012-03-15 发布日期:2012-03-15
  • 通讯作者: 程爱娟

Effects of Atorvastatin on Serum Concentration of PAPP-A and C-reative Protein Levels with Acute Coronary Syndrome

  • Received:2011-05-03 Revised:2011-06-06 Published:2012-03-15 Online:2012-03-15

摘要: 摘要:目的 探讨阿托伐他汀对急性冠脉综合症患者血清妊娠相关蛋白-A(pregnancy-associated plasma protein-A,PAPP-A)和C反应蛋白(c-reative protein,CRP)的影响。方法 测定90例正常对照组和105例急性冠脉综合症患者血清PAPP-A、CRP的浓度,所得结果进行统计分析。急性冠脉综合症组患者随机分为两组,分别应用阿托伐他汀20mg、10mg治疗一周后再次测定PAPP-A及CRP浓度,观察不同剂量之间的治疗效果。结果:急性冠脉综合症组患者PAPP-A及CRP浓度显著高于正常对照组;阿托伐他汀20mg治疗可显著降低PAPP-A及CRP浓度,与阿托伐他汀10mg相比有统计学意义(P<O.05)。结论:急性冠脉综合症患者PAPP-A和CRP血浆水平明显升高,阿托伐他汀可以降低ACS患者血清PAPP-A和CRP浓度,减轻炎症反应稳定冠脉粥样硬化斑块,并且这种机制与剂量相关。

关键词: 阿托伐他汀, 急性冠脉综合症, 妊娠相关蛋白-A, C反应蛋白

Abstract: Abstract:Objectives To investigate the effects of atorvastatin on selllm concentration of PAPP—A and c-reative protein(CRP) levels in patients with acute coronary syndrome.Methods We measured the serum concentrations of PAPP-A、CRP levels before and after treatment with atorvastatin 20mg、10mg in 105 ACS cases and 90 cases of control group.Results PAPP-A and CRP levels in patients with ACS were significantly higher than control group patients before intervention. There was obvious difference of PAPP-A、CRP levels in atorvastatin 20mg group and atorvastatin 10mg group after one week treatment(P<O.05). Conclusions PAPP-A and CRP levels in patients with ACS were significantly greater than control group. Atorvastatin can significantly reduce the PAPP-A and CRP levels in ACS patients, especially in atorvastatin 20mg group.

Key words: atorvastatin, acute coronary syndrome, pregnancy-associated plasma protein-A, C-reative Protein Levels